Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants

NCT00438230 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Deep Vein Thrombosis

Interventions

DRUG: Warfarin

Sponsor

Azienda Ospedaliera Universitaria Policlinico